Literature DB >> 12875612

Identification of adverse drug reactions in geriatric inpatients using a computerised drug database.

Tobias Egger1, Harald Dormann, Gabi Ahne, Ulrich Runge, Antje Neubert, Manfred Criegee-Rieck, Karl G Gassmann, Kay Brune.   

Abstract

INTRODUCTION AND
OBJECTIVE: Geriatric patients with multiple comorbidities are at high risk of experiencing an adverse drug reaction (ADR) during hospitalisation. The aim of the study was to compare the rate of ADRs as predicted by a computerised pharmacological database to the actual rate determined by direct observation in a sample of geriatric patients. STUDY
DESIGN: During a 4-month period, geriatric patients were monitored using prospective observation. Patients were intensively screened for ADRs by a pharmacoepidemiological team (PET), consisting of two pharmacists and a physician. Actual ADRs detected by the PET were compared with those predicted by a computerised drug database. Furthermore, the set of actual ADRs, which resulted from drug-drug interactions (DDIs), were contrasted with potential DDIs signalled by the database. The main outcome measures were the incidence of actual ADRs. For the detection rate of the database we focused on frequent ADRs (>1% according to product information and database) and all DDIs indicated automatically by the database.
RESULTS: 163 patients (121 female), mean age 79.8 +/- 7.1 years (range 60-98), were included in the study which was conducted on a geriatric rehabilitation hospital ward. The mean duration of hospitalisation was 24.3 +/- 8.4 days. Elderly patients received an average of 14.0 drugs (range 2-35) during their hospital stay. Of all patients, 60.7% experienced at least one ADR. The PET detected a total of 153 ADRs, with a mean of 0.9 ADRs per patient (range 0-5). The computerised drug database predicted an average of 309 potential ADRs for each patient; however, only 21 ADRs per patient were of high frequency. In 48% of ADR-positive patients (defined by PET) at least one of these frequent ADRs occurred.DDIs were detected by the PET in 14.7% of patients. Our database indicated a mean of 12 potential DDIs per patient. In 14 out of 24 DDI-positive patients, at least one signal indicated a real DDI. The database sensitivity was consequently 58.3%.
CONCLUSION: In geriatric patients the incidence of ADRs is high. Computerised drug databases are a useful tool for detecting and avoiding ADRs. Our software, however, also produced a large number of signals that did not relate to actual ADRs found by the PET. The sheer number of these 'false' signals shows the need for refinement and optimisation of databases for daily clinical use.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875612     DOI: 10.2165/00002512-200320100-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  26 in total

1.  Comparison of two knowledge bases on the detection of drug-drug interactions.

Authors:  G Del Fiol; B H Rocha; G J Kuperman; D W Bates; P Nohama
Journal:  Proc AMIA Symp       Date:  2000

2.  Evaluation of six computerized drug interaction screening programs.

Authors:  C A Jankel; B C Martin
Journal:  Am J Hosp Pharm       Date:  1992-06

3.  Focusing on the preventability of adverse drug reactions.

Authors:  G T Schumock; J P Thornton
Journal:  Hosp Pharm       Date:  1992-06

4.  The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II.

Authors:  L L Leape; T A Brennan; N Laird; A G Lawthers; A R Localio; B A Barnes; L Hebert; J P Newhouse; P C Weiler; H Hiatt
Journal:  N Engl J Med       Date:  1991-02-07       Impact factor: 91.245

5.  Drugs and adverse drug reactions: how worried should we be?

Authors:  D W Bates
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

6.  Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report.

Authors:  A K Jha; G J Kuperman; J M Teich; L Leape; B Shea; E Rittenberg; E Burdick; D L Seger; M Vander Vliet; D W Bates
Journal:  J Am Med Inform Assoc       Date:  1998 May-Jun       Impact factor: 4.497

Review 7.  Mechanisms of unpredictable adverse drug reactions.

Authors:  M J Rieder
Journal:  Drug Saf       Date:  1994-09       Impact factor: 5.606

Review 8.  Old age--is it a risk for adverse drug reactions?

Authors:  J H Gurwitz; J Avorn
Journal:  Agents Actions Suppl       Date:  1990

Review 9.  Epidemiology of adverse drug reactions in the elderly by drug class.

Authors:  R J Beyth; R I Shorr
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 4.271

10.  Proposed declassification of disease categories related to sexual orientation in the International Statistical Classification of Diseases and Related Health Problems (ICD-11).

Authors:  Susan D Cochran; Jack Drescher; Eszter Kismödi; Alain Giami; Claudia García-Moreno; Elham Atalla; Adele Marais; Elisabeth Meloni Vieira; Geoffrey M Reed
Journal:  Bull World Health Organ       Date:  2014-06-17       Impact factor: 9.408

View more
  34 in total

Review 1.  Pharmacovigilance in pediatrics: current challenges.

Authors:  Antje Neubert
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

2.  Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.

Authors:  Aileen B Dequito; Peter G M Mol; Jasperien E van Doormaal; Rianne J Zaal; Patricia M L A van den Bemt; Flora M Haaijer-Ruskamp; Jos G W Kosterink
Journal:  Drug Saf       Date:  2011-11-01       Impact factor: 5.606

3.  Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.

Authors:  Roberto Leone; Lara Magro; Ugo Moretti; Paola Cutroneo; Martina Moschini; Domenico Motola; Marco Tuccori; Anita Conforti
Journal:  Drug Saf       Date:  2010-08-01       Impact factor: 5.606

Review 4.  Polypharmacy in older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Arti Hurria
Journal:  Oncologist       Date:  2010-04-24

5.  Cytochrome p450 polymorphisms in geriatric patients: impact on adverse drug reactions--a pilot study.

Authors:  Tobias Egger; Harald Dormann; Gabi Ahne; Andreas Pahl; Ulrich Runge; Tanya Azaz-Livshits; Antje Neubert; Manfred Criegee-Rieck; Karl G Gassmann; Kay Brune
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  Detection of medication-related problems in hospital practice: a review.

Authors:  Elizabeth Manias
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

7.  A limited number of prescribed drugs account for the great majority of drug-drug interactions.

Authors:  Johan Holm; Birgit Eiermann; Erik Eliasson; Buster Mannheimer
Journal:  Eur J Clin Pharmacol       Date:  2014-09-06       Impact factor: 2.953

8.  [Pharmacist rounds on geriatric wards : Assessment of 1 year of pharmaceutical counseling].

Authors:  A Rösler; P Mißbach; F Kaatz; D Kopf
Journal:  Z Gerontol Geriatr       Date:  2016-07-15       Impact factor: 1.281

Review 9.  Drug-related problems in hospitals: a review of the recent literature.

Authors:  Anita Krähenbühl-Melcher; Raymond Schlienger; Markus Lampert; Manuel Haschke; Jürgen Drewe; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

10.  Effect of the cytochrome P450 2C19 inhibitor omeprazole on the pharmacokinetics and safety profile of bortezomib in patients with advanced solid tumours, non-Hodgkin's lymphoma or multiple myeloma.

Authors:  David I Quinn; John Nemunaitis; Jyotsna Fuloria; Carolyn D Britten; Nashat Gabrail; Lorrin Yee; Milin Acharya; Kai Chan; Nadine Cohen; Assen Dudov
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.